Hakkımızda İletişim Etkileşimler: 118 620
Ada göre bir ilaç arayın

Sudafed PSE ve Anemi

Sudafed PSE ilacının Anemi hastalığı ile etkileşiminin güvenlik kontrolünün sonucu.

Kontrolün sonucu:
Sudafed PSE <> Anemi
Güncellik: 23.07.2019 Eleştirmen: MD PHD P.M. Shkutko, in

Drugs.com, Rxlist.com, Webmd.com, Medscape.com gibi yetkili kaynaklara dayalı kontrolün sonucunda bu ilacın bu komorbid hastalık ile etkileşmesi halinde zarar verebilen veya olumsuz etkisini artırabilen kontrendikasyonlar veya yan etkiler bulundu.

Tüketici:

Doz serum hemoglobin ve hematokrit bağımlı olarak azaltır (NSAID), steroid olmayan anti-enflamatuar ilaçlar ile tedavi edilen hastalarda görülmüştür. Anemi bazen bildirilmiştir. Mekanizması türleri üzerinde NSAID bağlı sıvı tutulması veya gastrointestinal kan kaybı ya da eksik anlatılan bir etki içerebilir. Hemoglobin konsantrasyonu azalır ortalama doz hafif olma eğilimindedir, ancak yüksek dozlarda verildiğinde 1 g/dL, bu osteoartrit veya romatoid artrit tedavisinde kullanılan gibi aşabilir. Bu etkiler genellikle aksi takdirde sağlıklı bireyler olarak değil klinik olarak önemli olmakla birlikte, hastalarda anemi veya ciddi kan kaybı olan ilgili olabilir. NSAID ile tedavi dikkatli olan hastalarda uygulanan ya da anemi yatkın olmalıdır. Hematopoetik fonksiyonu klinik izleme uygun olabilir, özellikle de kronik tedavi sırasında olabilir.

Kaynaklar
  • "Product Information. Relafen (nabumetone)." SmithKline Beecham, Philadelphia, PA.
  • Salom IL, Jacob G, Jallad N, Perdomo CA, Mullane JF, Weidler D "Gastrointestinal microbleeding associated with the use of etodolac, ibuprofen, indomethacin, and naproxen in normal males." J Clin Pharmacol 24 (1984): 240-6
  • "Product Information. Celebrex (celecoxib)." Searle, Chicago, IL.
  • Johnson FP Jr, Hamilton HE, Liesch MR "Immune hemolytic anemia associated with sulindac." Arch Intern Med 145 (1985): 1515-6
  • "Product Information. Indocin (indomethacin)." Merck & Co, Inc, West Point, PA.
  • Squires JE, Mintz PD, Clark S "Tolmetin-induced hemolysis." Transfusion 25 (1985): 410-3
  • Kornberg A, Rachmilewitz EA "Aplastic anemia after prolonged ingestion of indomethacin." Acta Haematol 67 (1982): 136-8
  • Eustace S, O'Neill T, McHale S, Molony J "Fatal aplastic anaemia following prolonged diclofenac use in an elderly patient." Ir J Med Sci 158 (1989): 217
  • Catalano MA "Worldwide safety experience with diclofenac." Am J Med 80 (1986): 81-7
  • "Product Information. Lodine (etodolac)." Wyeth-Ayerst Laboratories, Philadelphia, PA.
  • "Product Information. Ansaid (flurbiprofen)." Pharmacia and Upjohn, Kalamazoo, MI.
  • "Product Information. Clinoril (sulindac)." Merck & Co, Inc, West Point, PA.
  • Randi ML, Tison T, Luzzatto G "Haemolytic uraemic syndrome during treatment with ketorolac trometamol." BMJ 306 (1993): 186
  • Sanz MA, Martinez JA, Gomis F, Garcia-Borras JJ "Sulindac-induced bone marrow toxicity." Lancet 2 (1980): 802-3
  • Bernhard GC "Worldwide safety experience with nabumetone." J Rheumatol 19 (1992): 48-57
  • "Product Information. Tolectin (tolmetin)." McNeil Pharmaceutical, Raritan, NJ.
  • "Product Information. Dolobid (diflunisal)." Merck & Co, Inc, West Point, PA.
  • Ashraf M, Pearson RM, Winfield DA "Aplastic anaemia associated with fenoprofen." Br Med J 284 (1982): 1301-2
  • Andrews R, Russell N "Aplastic anaemia associated with a non-steroidal anti-inflammatory drug: relapse after exposure to another such drug." Br Med J 301 (1990): 38
  • Lee SH, Fawcett V, Preece JM "Aplastic anaemia associated with piroxicam." Lancet 1 (1982): 1186
  • Reitz CL, Bottomley SS "Pure red cell aplasia associated with fenoprofen." Am J Med Sci 287 (1984): 62-3
  • Sanada M, Takai K "Aplastic anaemia associated with piroxicam." Br J Haematol 77 (1991): 256-7
  • Miller JL "Marrow aplasia and sulindac." Ann Intern Med 92 (1980): 129
  • "Product Information. Naprosyn (naproxen)." Syntex Laboratories Inc, Palo Alto, CA.
  • Brooks CD, Linet OI, Schellenberg D, Turner LF, Defesche CL, Teoh KW, Johnson JH, Assenzo JR "Clinical safety of flurbiprofen." J Clin Pharmacol 30 (1990): 342-51
  • Schattenkirchner M "An updated safety profile of etodolac in several thousand patients." Eur J Rheumatol Inflamm 10 (1990): 56-65
  • Hughes JA, Sudell W "Hemolytic anemia associated with naproxen." Arthritis Rheum 26 (1983): 1054
  • Kramer MR, Levene C, Hershko C "Severe reversible autoimmune haemolytic anaemia and thrombocytopenia associated with diclofenac therapy." Scand J Haematol 36 (1986): 118-20
  • Lopez A, Linares M, Sanchez H, Blanquer A "Autoimmune hemolytic anemia induced by diclofenac." Ann Pharmacother 29 (1995): 787
  • "Product Information. Toradol (ketorolac)." Roche Laboratories, Nutley, NJ.
  • McNeil P, MacKenzie I, Manoharan A "Naproxen-associated aplastic anaemia." Med J Aust 145 (1986): 53-5
  • Lussier A, LeBel E "Radiochromium (chromium-51) evaluation of gastrointestinal blood loss associated with placebo, aspirin, and nabumetone." Am J Med 83 (1987): 15-8
  • "Product Information. Vioxx (rofecoxib)." Merck & Co, Inc, West Point, PA.
  • "Product Information. Motrin (ibuprofen)." Pharmacia and Upjohn, Kalamazoo, MI.
  • van Dijk BA, Rico PB, Hoitsma A, Kunst VA "Immune hemolytic anemia associated with tolmetin and suprofen." Transfusion 29 (1989): 638-41
  • Schattner A, Shtalrid M, Levy R, Berrebi A "Fatal aplastic anemia due to indomethacin: lymphocyte transformation tests in vitro." Isr J Med Sci 17 (1981): 433-6
  • Green D, Davies RO, Holmes GI et al "Effects of diflunisal on platelet function and fecal blood loss." Pharmacotherapy 3 (1983): s65-9
  • "Product Information. Nalfon (fenoprofen)." Xspire Pharma, Ridgeland, MS.
  • "Product Information. Orudis (ketoprofen)." Wyeth-Ayerst Laboratories, Philadelphia, PA.
  • "Product Information. Bextra (valdecoxib)." Pharmacia Corporation, Peapack, NJ.
  • Bennett L, Schlossman R, Rosenthal J, et al "Aplastic anemia and sulindac." Ann Intern Med 92 (1980): 874
  • Arnold R, Heimpel H "Aplastic anaemia after naproxen?" Lancet 02/09/80 (1980): 321
  • Angeles ML, Reid ME, Yacob UA, Cash KL, Fetten JV "Sulindac-induced immune hemolytic anemia." Transfusion 34 (1994): 255-8
  • Gerber D "Adverse reactions of piroxicam." Drug Intell Clin Pharm 21 (1987): 707-10
  • "Product Information. Voltaren (diclofenac)." Novartis Pharmaceuticals, East Hanover, NJ.
  • "Product Information. Feldene (piroxicam)." Pfizer US Pharmaceuticals, New York, NY.
  • "Product Information. Daypro (oxaprozin)." Searle, Skokie, IL.
  • Salama A, Gottsche B, Mueller-Eckhardt C "Autoantibodies and drug- or metabolite-dependent antibodies in patients with diclofenac-induced immune haemolysis." Br J Haematol 77 (1991): 546-9
  • "Product Information. Mobic (meloxicam)" Boehringer-Ingelheim, Ridgefield, CT.
Sudafed PSE

Jenerik adı: naproxen / pseudoephedrine

Marka adı: Aleve Cold and Sinus, Aleve Sinus & Headache, Aleve-D Sinus & Cold, Sudafed PSE, Aleve-D Cold and Sinus, Sudafed Sinus & Pain 12 Hour, Sinus & Cold-D, Sudafed Sinus 12 Hour Pressure + Pain, Aleve-D Sinus & Headache, Sudafed 12 Hour Pressure + Pain

Eşdeğer ilaçlar: Naproxen and pseudoephedrine

Gıda ve yaşam tarzı ile etkileşim
Ilaç etkileşimlerini